A Latvian start-up recognised in European healthcare accelerator programme

Headstart, one of the flagship EIT Health healthcare accelerator programs, has just announced this year’s semi-finalists who will conquer for investors’ attention, mentoring, funding support, and the place on the podium during Grand Finals in the second half of the year.

In the Headstart Programme, EIT Health decided to support 89 healthcare start-ups in Europe, including 17 teams from more progressing regions. Seven start-ups come from Italy, two from Portugal, Poland, and Estonia and one from Greece, Romania, Hungary, and Latvia. All the teams get €40 000 to develop their innovations and entice private investment. Start-ups will compete for an additional €10 000 during the Finals.
The Latvian Headstart semi-finalist is Longenesis SIA. Company’s solution supports COVID-19 research with a technological toolkit that assists with legal challenges of patient access – the tool is GDPR and HIPA compliant and offers the ability to safely showcase patient data to clinical investigators and researchers without releasing personal information.